Transplantation of cancer cells engineered to secrete FKN in mouse models for lung adenocarcinoma leads to a significant reduction in tumor growth [64,67], which can be replicated by systemic administration of recombinant protein [67]. Here, CX3CL1 is linked to lung adenocarcinoma.